
Patrick Forde/Facebook
Aug 23, 2025, 15:49
Patrick Forde: The Final Survival Results of Neoadjuvant Nivolumab in Lung Cancer
Patrick Forde, Professor at The Johns Hopkins University, shared on X:
“Published in today’s print edition of NEJM the final survival results of neoadjuvant nivo in lung cancer along with a 2 min quick take video & an elegant editorial from Dr. Virginia Calvo.”
Title: Neoadjuvant Nivolumab in Resectable Lung Cancer
More posts featuring Lung Cancer.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 23, 2025, 15:39
Aug 23, 2025, 15:30
Aug 23, 2025, 15:25
Aug 23, 2025, 15:21
Aug 23, 2025, 14:56
Aug 23, 2025, 14:52
Aug 23, 2025, 14:36